COMMUNIQUÉS West-GlobeNewswire

Relmada Therapeutics Presents Positive Initial Phase 2 NDV-01 Data at AUA2025

28/04/2025 - 19:38

90% of patients achieved high grade disease-free status at any time point with NDV-01, demonstrating strong proof-of-concept for sustained-release “GEM/DOCE” formulation* NDV-01 showed promising clinical activity in BCG [...]

Sugar Defender Reviews [Blood Sugar Control Supplement 2025] User Complaints, Ingredients and Possible Side Effects?

28/04/2025 - 20:13

Sugar Defender's Secret Formula Finally Revealed – How It Supports Healthy Blood Sugar Naturally Albany, New York, April 28, 2025 (GLOBE NEWSWIRE) -- Sugar Defender's Secret Formula Finally Revealed – Know How It [...]

Best Testosterone Boosters for Muscle Gain: Top Rated Testosterone Pills for Bodybuilding & Muscle Growth From TestoPrime

28/04/2025 - 20:15

Boost muscle gain, crush erectile dysfunction, and reclaim peak vitality naturally with top natural testosterone boosters like TestoPrime, powered by D-Aspartic Acid, Fenugreek, KSM-66 Ashwagandha, and Panax Ginseng. [...]

Supra Keto ACV Gummies: Best Gummies for Weight Loss 2025 - (Keto BHB + Keto Plus)

28/04/2025 - 20:32

New York, April 28, 2025 (GLOBE NEWSWIRE) -- Within the weight loss supplement industry, Supra Keto BHB + ACV Gummies are revolutionary, employing two of the best fat-burning compounds: Beta-Hydroxybutyrate (BHB) and [...]

Frontier Medicines Unveils New Preclinical Data for FMC-220, a First-in-Class Covalent p53 Y220C Activator, at AACR 2025

28/04/2025 - 21:30

Sustained reactivation of mutant p53 drives durable anti-tumor activity across models, including KRAS co-mutant tumors FMC-220 selectively stabilizes p53 Y220C at lower doses, overcoming key limitations of non-covalent [...]

Cronos Group Inc. to Hold Virtual 2025 Annual Meeting of Shareholders

28/04/2025 - 22:00

TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 Annual Meeting of Shareholders on Friday, June 20, 2025, at 11:00 a.m. ET. Cronos [...]

CytomX Therapeutics Presents Preclinical Data for mRNA Encoded Masked IL-12 Molecule in Collaboration with Moderna at AACR Annual Meeting

28/04/2025 - 22:00

Novel engineering approach to developing an mRNA-encoded masked IL-12 therapeutic demonstrates potent anti-tumor activity with significantly enhanced tolerability SOUTH SAN FRANCISCO, Calif., April 28, 2025 (GLOBE [...]

Nurix Therapeutics Presents Data at the AACR 2025 Annual Meeting Highlighting the Transformative Potential of Its Proprietary DEL-AI Platform Leveraging Machine Learning to Speed the Discovery of Novel Drugs

28/04/2025 - 22:00

Nurix’s DEL-AI platform uses a first-in-class DEL Foundation Model trained on the Company’s proprietary DNA encoded library data Nurix’s DEL Foundation Model can accurately predict novel binders to therapeutically [...]

Olon Group Strengthens Its Leadership in Bioproduction with Two Strategic Appointments in France

28/04/2025 - 16:01

MILAN, April 28, 2025 (GLOBE NEWSWIRE) -- Olon Group, a leading global pharmaceutical CDMO, announces the appointment of Jérôme Bédier as CEO of its French entities and Andrea Conforto as M&S VP CDMO of Olon Biotech [...]

A New Name. A Global Mission. Introducing SafeSpace Global Corporation

28/04/2025 - 16:10

Knoxville, TN, April 28, 2025 (GLOBE NEWSWIRE) -- Healthcare Integrated Technologies is proud to announce a major milestone in its evolution: the Company has officially rebranded as SafeSpace Global Corporation (OTC [...]

Coherus Presents Promising Early Clinical Data from Phase 1 Dose Expansion Study of CHS-114 in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma at AACR 2025

28/04/2025 - 16:10

– CHS-114 demonstrates clinical efficacy and proof of mechanism in HNSCC in combination with toripalimab – – Confirmed partial response in heavily pretreated PD-1 refractory patient supports expansion in HNSCC and [...]

Jade Biosciences Completes Closing of Merger with Aerovate Therapeutics and Previously Announced Private Placement of Approximately $300 Million

28/04/2025 - 16:18

Company is advancing portfolio of novel therapies that aim to redefine the standard of care for patients with autoimmune diseases Lead candidate JADE-001 on track to enter the clinic in second half of 2025, with initial [...]

BioPorto A/S to host first quarter 2025 earnings webcast for investors

28/04/2025 - 16:41

April 28, 2025 News release BioPorto A/S to host first quarter 2025 earnings webcast for investors COPENHAGEN, DENMARK, April 28, 2025 (GLOBE NEWSWIRE) – BioPorto A/S (BioPorto or the Company) (CPH:BIOPOR), an in vitro [...]

Best Place To Buy SARMs Online 2025 - Top 3 Best Brands of Sarms (Trusted Sites with Sarms for Sale) - By Crazybulk

28/04/2025 - 17:21

New York City, April 28, 2025 (GLOBE NEWSWIRE) -- If you wish to buy SARMs online and want to know where to buy the most effective SARMs, whether you desire muscle gain, weight loss, or even both, the following article [...]

Yaqrit showcases clinical progress at the European Association for the Study of the Liver (EASL) Congress, May 7-10th

28/04/2025 - 17:27

Shared data underpins key advanced trials in hepatic encephalopathy, acute-on-chronic liver failure (ACLF) and decompensated cirrhosis Management attending conference LONDON, April 28, 2025 (GLOBE NEWSWIRE) -- Yaqrit, a [...]

Eurobio Scientific : RESULTAT ANNUEL 2024 - Croissance du cœur d’activité et déploiement stratégique

28/04/2025 - 17:46

RESULTAT ANNUEL 2024 Croissance du cœur d’activité et déploiement stratégique Chiffre d’affaires en croissance de 19% à 154 M€ ; la croissance à périmètre constant est de +9% les produits propriétaires stables à 31% du [...]

Eurobio Scientific: 2024 annual results

28/04/2025 - 17:46

2024 ANNUAL RESULTS Growth of core business and strategic execution Revenue up 19% to €154 million Organic growth at +9% Proprietary products account for a stable 31% of group revenue International accounts for 41% of [...]

Press release: Sequana Medical Announces New Share Capital Amount and New Number of Shares

28/04/2025 - 18:00

SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES Ghent, Belgium, 28 April 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company " or " Sequana Medical "), a pioneer in the [...]

MITOLYN REVIEWS: Does It Really Work for Weight Loss or Is It a Scam?

28/04/2025 - 18:08

New York City, April 28, 2025 (GLOBE NEWSWIRE) -- a very potent dietary supplement, Mitolyn was developed specifically for the purpose of promoting weight loss and general well-being . By regulating hormone levels and [...]